NFκB is persistently active in a number of human diseases, including sepsis, cancer, arthritis, chronic inflammation, asthma, neurodegenerative diseases, metabolic disease, and heart disease8, 9, 10, and thus, effective and safe inhibitors of NFκB would have wide-ranging therapeutic use. This evidence concerns the gene NFKB1 and Sepsis.